Aqemia
Aqemia is a drug discovery company that utilizes generative AI and deep physics to develop a pipeline of new medicines. The platform aims to advance drug discovery beyond conventional methods by integrating science engines to scale the invention of therapeutic compounds. Their work focuses on the pharmaceutical and biotechnology markets through a proprietary discovery pipeline.
Healthtech
Biotechnology
Artificial Intelligence
Pharmaceuticals
Funding summary
- Total raised
- €233.3M
- Funding rounds
- 6
Investors in Aqemia
Investors on record for Aqemia. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Aqemia?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors